Item Type | Name |
Concept
|
Otoacoustic Emissions, Spontaneous
|
Concept
|
Cytokines
|
Concept
|
Tandem Mass Spectrometry
|
Concept
|
Enzyme-Linked Immunosorbent Assay
|
Concept
|
Neutrophils
|
Concept
|
Disease Models, Animal
|
Concept
|
Calcium Channel Blockers
|
Concept
|
Vestibular Diseases
|
Concept
|
Brain Neoplasms
|
Concept
|
Amyloid beta-Protein Precursor
|
Concept
|
Microscopy, Electron
|
Concept
|
RNA, Small Interfering
|
Concept
|
Internship and Residency
|
Concept
|
Data Interpretation, Statistical
|
Concept
|
2,4-Dinitrophenol
|
Concept
|
Heat-Shock Proteins
|
Concept
|
Evoked Potentials, Auditory, Brain Stem
|
Concept
|
Mitochondria
|
Concept
|
Incidence
|
Concept
|
Epidural Abscess
|
Concept
|
Bone Morphogenetic Protein 7
|
Concept
|
Recurrence
|
Concept
|
Osteocytes
|
Concept
|
p38 Mitogen-Activated Protein Kinases
|
Concept
|
Magnetic Resonance Imaging
|
Concept
|
Spinal Fusion
|
Concept
|
Membrane Potentials
|
Concept
|
Mutagenesis, Site-Directed
|
Concept
|
Ileum
|
Concept
|
Microarray Analysis
|
Concept
|
Polymorphism, Single Nucleotide
|
Concept
|
Fluorescent Antibody Technique
|
Concept
|
Disease Progression
|
Concept
|
Long-Term Potentiation
|
Concept
|
Lipid Bilayers
|
Concept
|
Ceramides
|
Concept
|
Dantrolene
|
Concept
|
Axons
|
Concept
|
Registries
|
Concept
|
Treatment Outcome
|
Concept
|
Macrophages
|
Concept
|
Taurocholic Acid
|
Concept
|
Hearing Disorders
|
Concept
|
Cricetinae
|
Concept
|
Orthopedic Procedures
|
Concept
|
Clostridium septicum
|
Concept
|
Antigens, CD1
|
Concept
|
Lysosomes
|
Concept
|
Molecular Biology
|
Concept
|
Amino Acid Substitution
|
Concept
|
Sirolimus
|
Concept
|
Animals
|
Concept
|
Interviews as Topic
|
Concept
|
Binding, Competitive
|
Concept
|
Neurodegenerative Diseases
|
Concept
|
Unnecessary Procedures
|
Concept
|
Psychosine
|
Concept
|
Workload
|
Concept
|
Magnetic Resonance Angiography
|
Concept
|
Models, Immunological
|
Concept
|
Synaptic Transmission
|
Concept
|
Amino Acid Sequence
|
Concept
|
Neurogenesis
|
Concept
|
Mice, Knockout
|
Concept
|
Immunosuppressive Agents
|
Concept
|
Antibodies
|
Concept
|
Inositol
|
Concept
|
Blotting, Western
|
Concept
|
Antigens, Differentiation, Myelomonocytic
|
Concept
|
Neuroprotective Agents
|
Concept
|
Cricetulus
|
Concept
|
Genetic Predisposition to Disease
|
Concept
|
Longevity
|
Concept
|
Dose-Response Relationship, Drug
|
Concept
|
Mitogen-Activated Protein Kinase 13
|
Concept
|
Infusions, Intravenous
|
Concept
|
Postoperative Complications
|
Concept
|
Calreticulin
|
Concept
|
Carcinogens
|
Concept
|
Spectrometry, Mass, Electrospray Ionization
|
Concept
|
Mice
|
Concept
|
Functional Laterality
|
Concept
|
DNA Primers
|
Concept
|
Models, Biological
|
Concept
|
Injury Severity Score
|
Concept
|
Tumor Necrosis Factor-alpha
|
Concept
|
Cecum
|
Concept
|
Intercellular Signaling Peptides and Proteins
|
Concept
|
Dinoprostone
|
Concept
|
Personnel Selection
|
Concept
|
Cerebral Cortex
|
Concept
|
Saposins
|
Concept
|
Communicable Diseases, Emerging
|
Concept
|
5' Flanking Region
|
Concept
|
Mice, Inbred C57BL
|
Concept
|
Hair Cells, Ampulla
|
Concept
|
Retrospective Studies
|
Concept
|
Keloid
|
Concept
|
Mice, Transgenic
|
Concept
|
T-Lymphocytes
|
Concept
|
Chromatography, Thin Layer
|
Concept
|
Organ Culture Techniques
|
Concept
|
Tetradecanoylphorbol Acetate
|
Concept
|
Antigens, CD
|
Concept
|
Correspondence as Topic
|
Concept
|
Microtubule-Associated Proteins
|
Concept
|
Cathepsin D
|
Concept
|
Cicatrix
|
Concept
|
Lipoproteins
|
Concept
|
Intestine, Small
|
Concept
|
Immunoglobulin G
|
Concept
|
RNA, Messenger
|
Concept
|
Multiple Myeloma
|
Concept
|
Humans
|
Concept
|
Esophagus
|
Concept
|
Nerve Degeneration
|
Concept
|
Hearing Loss
|
Concept
|
Cell Movement
|
Concept
|
Gait
|
Concept
|
Memory Disorders
|
Concept
|
Doxycycline
|
Concept
|
Apolipoprotein A-I
|
Concept
|
Membrane Transport Proteins
|
Concept
|
Glucosylceramides
|
Concept
|
Protein Structure, Tertiary
|
Concept
|
Adaptor Proteins, Signal Transducing
|
Concept
|
Lysosome-Associated Membrane Glycoproteins
|
Concept
|
Inhibitory Concentration 50
|
Concept
|
Psychomotor Performance
|
Concept
|
Macrophages, Peritoneal
|
Concept
|
Autoantibodies
|
Concept
|
Inflammation
|
Concept
|
Bone Transplantation
|
Concept
|
Mice, Inbred NOD
|
Concept
|
Catalytic Domain
|
Concept
|
Neutralization Tests
|
Concept
|
Health Care Surveys
|
Concept
|
Liposomes
|
Concept
|
Survival Analysis
|
Concept
|
Cluster Analysis
|
Concept
|
Detergents
|
Concept
|
ATP-Binding Cassette Transporters
|
Concept
|
Green Fluorescent Proteins
|
Concept
|
Receptor, Anaphylatoxin C5a
|
Concept
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
|
Concept
|
Reverse Transcriptase Polymerase Chain Reaction
|
Concept
|
Enzyme Stability
|
Concept
|
Thymus Gland
|
Concept
|
Imino Pyranoses
|
Concept
|
Immune Evasion
|
Concept
|
Low Back Pain
|
Concept
|
Phosphatidylserines
|
Concept
|
Lysosomal-Associated Membrane Protein 2
|
Concept
|
Glycosphingolipids
|
Concept
|
Swimming
|
Concept
|
Calnexin
|
Concept
|
Myelin Basic Protein
|
Concept
|
Calcium Channels, L-Type
|
Concept
|
Interleukin-8
|
Concept
|
Lymph Nodes
|
Concept
|
Mice, SCID
|
Concept
|
Prevalence
|
Concept
|
Case-Control Studies
|
Concept
|
Lewy Body Disease
|
Concept
|
Mutagenesis
|
Concept
|
Chemokine CCL2
|
Concept
|
Induced Pluripotent Stem Cells
|
Concept
|
Calcium Signaling
|
Concept
|
Sphingomyelins
|
Concept
|
Reproducibility of Results
|
Concept
|
Diskectomy
|
Concept
|
Prospective Studies
|
Concept
|
Leukodystrophy, Metachromatic
|
Concept
|
Wolman Disease
|
Concept
|
Cross-Sectional Studies
|
Concept
|
Rats
|
Concept
|
Gaucher Disease
|
Concept
|
Interleukin-6
|
Concept
|
Spleen
|
Concept
|
Models, Chemical
|
Concept
|
Models, Molecular
|
Concept
|
Enzyme Replacement Therapy
|
Concept
|
Surveys and Questionnaires
|
Concept
|
Enzyme Inhibitors
|
Concept
|
Lysosomal Storage Diseases
|
Concept
|
Breast Neoplasms
|
Concept
|
Glucocorticoids
|
Concept
|
Oligonucleotide Array Sequence Analysis
|
Concept
|
B-Lymphocytes
|
Concept
|
Practice Patterns, Physicians'
|
Concept
|
Point Mutation
|
Concept
|
Coronavirus Infections
|
Concept
|
Integrin alpha4beta1
|
Concept
|
Ryanodine Receptor Calcium Release Channel
|
Concept
|
Polymerase Chain Reaction
|
Concept
|
Hippocampus
|
Concept
|
United States
|
Concept
|
Protein Conformation
|
Concept
|
Parkinson Disease
|
Concept
|
Receptors, Scavenger
|
Concept
|
Laser Therapy
|
Concept
|
Cholesterol
|
Concept
|
Risk Assessment
|
Concept
|
Atlanto-Axial Joint
|
Concept
|
Mutation, Missense
|
Concept
|
Risk
|
Concept
|
Gangliosides
|
Concept
|
MicroRNAs
|
Concept
|
Risk Factors
|
Concept
|
Chemokines
|
Concept
|
alpha-Synuclein
|
Concept
|
Bone Morphogenetic Protein 2
|
Concept
|
Promoter Regions, Genetic
|
Concept
|
Intraoperative Complications
|
Concept
|
Bone Substitutes
|
Concept
|
Vimentin
|
Concept
|
Base Sequence
|
Concept
|
Amino Acid Motifs
|
Concept
|
Follow-Up Studies
|
Concept
|
Killer Cells, Natural
|
Concept
|
Immunohistochemistry
|
Concept
|
Glioblastoma
|
Concept
|
Immune Tolerance
|
Concept
|
Injections, Intravenous
|
Concept
|
Mice, Mutant Strains
|
Concept
|
Immunoblotting
|
Concept
|
Cell Count
|
Academic Article
|
Neurological deficits and glycosphingolipid accumulation in saposin B deficient mice.
|
Academic Article
|
Multi-system disorders of glycosphingolipid and ganglioside metabolism.
|
Academic Article
|
Comparative therapeutic effects of velaglucerase alfa and imiglucerase in a Gaucher disease mouse model.
|
Academic Article
|
Acid ?-glucosidase mutants linked to Gaucher disease, Parkinson disease, and Lewy body dementia alter a-synuclein processing.
|
Academic Article
|
Gaucher disease glucocerebrosidase and a-synuclein form a bidirectional pathogenic loop in synucleinopathies.
|
Academic Article
|
Bone graft and bone graft substitutes in spine surgery: current concepts and controversies.
|
Academic Article
|
Tissue-specific effects of saposin A and saposin B on glycosphingolipid degradation in mutant mice.
|
Academic Article
|
Substrate compositional variation with tissue/region and Gba1 mutations in mouse models--implications for Gaucher disease.
|
Academic Article
|
Endogenous ?-glucocerebrosidase activity in Abca12?/?epidermis elevates ceramide levels after topical lipid application but does not restore barrier function.
|
Academic Article
|
Multiple pathogenic proteins implicated in neuronopathic Gaucher disease mice.
|
Academic Article
|
Ubiquitous transgene expression of the glucosylceramide-synthesizing enzyme accelerates glucosylceramide accumulation and storage cells in a Gaucher disease mouse model.
|
Academic Article
|
Modulating ryanodine receptors with dantrolene attenuates neuronopathic phenotype in Gaucher disease mice.
|
Academic Article
|
Complement drives glucosylceramide accumulation and tissue inflammation in Gaucher disease.
|
Academic Article
|
HIV in Orthopaedic Surgery.
|
Academic Article
|
Combination of acid ?-glucosidase mutation and Saposin C deficiency in mice reveals Gba1 mutation dependent and tissue-specific disease phenotype.
|
Academic Article
|
Ex vivo localization of the mouse saposin C activation region for acid beta-glucosidase.
|
Academic Article
|
Analyses of temporal regulatory elements of the prosaposin gene in transgenic mice.
|
Academic Article
|
Systemic enzyme delivery by blood-brain barrier-penetrating SapC-DOPS nanovesicles for treatment of neuronopathic Gaucher disease.
|
Concept
|
Total Disc Replacement
|
Concept
|
Mechanistic Target of Rapamycin Complex 1
|
Concept
|
ATP Binding Cassette Transporter 1
|
Concept
|
Glycoside Hydrolase Inhibitors
|
Concept
|
Spatial Memory
|
Concept
|
Protein Aggregation, Pathological
|
Concept
|
Betacoronavirus
|
Concept
|
Chitinase-3-Like Protein 1
|
Concept
|
Sequestosome-1 Protein
|
Concept
|
Mice, 129 Strain
|